Related references
Note: Only part of the references are listed.Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study (IBMS-II)
Andrew M. Blumenfeld et al.
HEADACHE (2013)
Rates and reasons for discontinuation of triptans and opioids in episodic migraine: Results from the American Migraine Prevalence and Prevention (AMPP) study
Starr Holland et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Predictors of Adherence to Triptans: Factors of Sustained vs Lapsed Users
Roger K. Cady et al.
HEADACHE (2009)
Impact of Recent Prior Opioid Use on Rizatriptan Efficacy. A Post Hoc Pooled Analysis
Tony W. Ho et al.
HEADACHE (2009)
Influence of disease features on adherence to prophylactic migraine medication
M. Linde et al.
ACTA NEUROLOGICA SCANDINAVICA (2008)
Patterns of use of triptans and reasons for switching them in a tertiary care migraine population
FD Sheftell et al.
HEADACHE (2004)
Migraine prevalence and treatment patterns: The global Migraine And Zolmitriptan Evaluation survey
EA MacGregor et al.
HEADACHE (2003)
Migraine diagnosis and treatment: Results from the American Migraine Study II
RB Lipton et al.
HEADACHE (2001)
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
SD Silberstein
NEUROLOGY (2000)
Share Paper
